GLP-1 use among young children with obesity in US remains rare but is rising rapidly

More kids age 8 to 11 are being prescribed weight loss drugs: study

Prescriptions for the drugs are on the rise in part because of how they work. They can help kids who need it shed up to 16% of their body weight, but it raises the obvious question: How will it affect them in the long term?

GLP-1 use in US kids under-12 soars - even without FDA approval

One in five children suffers from obesity, a chronic condition leaving them at greater risk of cancer and heart disease

GLP-1 use among young children with obesity in US remains rare but is rising rapidly

Although the number of U.S. children under age 12 with obesity who are prescribed the weight-loss drugs Saxenda, Wegovy and Zepbound remains low, it was 310 times higher in June 2026 than in 2019, when the drugs were first prescribed, a new study shows.